ALTERITY THERAPEUTICS-ADR (ATHE) Stock Analyst Earnings Estimates
NASDAQ:ATHE - Nasdaq - US02155X2053 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 2.5K -87.92% | 16.4K 556.00% | 268.4K 1,536.59% | |
| EBITDA YoY % growth | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.954M -3.79% | -14.622M 8.35% | -19.339M -32.26% | |
| Operating Margin | -638,144.00% | -89,157.32% | -7,205.10% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in AUD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in AUD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 111.3K -6.00% | % | ||
| Q4 2024 Q2Q % growth | 150K 2,841.18% | % | ||
| Q2 2024 Q2Q % growth | 118.4K 938.60% | % | ||
| Q4 2023 Q2Q % growth | 5.1K 325.00% | % | ||
| Q2 2023 Q2Q % growth | 11.4K 714.29% | % | ||
| Q4 2022 Q2Q % growth | 1.2K -91.49% | % | ||
| Q2 2022 Q2Q % growth | 1.4K -78.79% | % | ||
| Q4 2021 Q2Q % growth | 14.1K 370.00% | % | ||
| Q2 2021 Q2Q % growth | 6.6K -53.19% | % | ||
| Q4 2020 Q2Q % growth | 3K -92.89% | % | ||
| Q2 2020 Q2Q % growth | 14.1K -78.77% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |